About William Bologna

William Bologna co-founded one of the first publicly traded women’s health companies in the United States and went on to develop and license market-leading products in fertility and female sexual health including Crinone®, Replens®, RepHresh®, Striant® and Advantage-S.

Mr. Bologna has been granted more than 50 patents covering new drug delivery systems, unique pharmaceutical compositions and methods for treating women’s health disorders such as endometriosis, infertility, premature labor, dysmenorrhea, vaginal infections, among other conditions.

Mr. Bologna co-founded Nasdaq listed Columbia Laboratories (now Juniper Pharmaceuticals) in 1986 and during his tenure, the company was granted more than 50 patents and regulatory approval to sell its products in over 90 countries. Crinone®, Juniper Pharmaceuticals’ lead infertility product, is now marketed by Allergan and Merck KGaA, Darmstadt, Germany, in virtually every major country in the world and is still the only product approved by the Food and Drug Administration (FDA) for use within the first trimester of pregnancy. In his capacity as Chairman and Chief Scientific Officer, Mr. Bologna supervised the company’s regulatory affairs, product development, clinical development, manufacturing and quality control. In addition, Mr. Bologna founded a medical consulting, marketing and advertising company, Bologna International, in 1980, which provided services to multinational pharmaceutical companies.

Bachelor of Science in Pharmacy and MBA degrees from Fordham University. Mr. Bologna also attended the Columbia University Graduate School.